SCHILKE TOBIN (Chief Financial Officer) sold 7.9% of their position (6.71K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $266.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001628280-26-014772
Officer· Chief Financial Officer
Since Mar 2026
-6.71K
Net shares
Net seller
$266.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.71K
Price / share
$39.67
Trade value
$266.30K
% of position
7.9%
3/3/2026
84.83K→78.12K
Total
Net shares
−6.71K
Net value
-$266.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2026 | S · Sale | −6.71K | $39.67 | $266.30K | 7.9% | 84.83K | 78.12K |
| Total | −6.71K | -$266.30K | ||||||
Derivative Transactions0
No derivative transactions reported